Monday, November 16, 2026 Vol. I · No. 4
Health · Via STAT

STAT+: Biotech’s rebound isn’t lifting all boats equally

Image: STAT

Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk